ロシア製ワクチンは、スプートニックVという名前だ。

なんだか宇宙飛行を連想してしまうが、どうなんだろう、ロシア製ワクチンって？

記事には　インド、イタリア、ハンガリー、チェコ、スロバキア　などがスプートニックVワクチンの利用(検討を含む)方針であるし、英国のThe Lancet という著名医療ジャーナル誌,では　このロシアワクチンについて　安全であり有効性は91%になっていると説明している。

とは言え、やはり　ロシア製とか中国製のワクチンとなると、西側諸国の国民にとっては、なんだか心理的抵抗があるかもしれない。

Around the world, orders for Sputnik V have surged exponentially as more governments and regulators found the vaccine to be safe despite the initial scepticism about its hasty introduction and the Russian authorities' decision to roll them out before it had completed late-stage trials.

India, one of the world’s biggest vaccine producers, signed a partnership with RDIF in December, 2020, to produce 300 million doses of Sputnik V by this year.

On March 9, Italy entered a similar partnership to become the first country from the European Union, where geopolitics has fuelled strong anti-Russia sentiment, to produce the Sputnik V within the union.

The vaccine, however, has yet to get approval from EU regulators, but public health authorities in member nations like Hungary, Czech Republic and Slovenia have already declared the vaccine safe for public use.

Western perception of Sputnik V took a sharp turnaround after The Lancet, the esteemed UK-based peer-reviewed medical journal, published a study that found Sputnik V safe and with a 91 per cent efficacy rate.

The vaccine also appeared to prevent those who have taken it from becoming severely ill with Covid-19, the study found.

It remains unclear, however, if it can prevent the spread of the disease.

なお、現時点では　マレーシアがロシア製ワクチンを使うかについて　ドクターNoorはまだUnder Review中だとしている。

The National Pharmaceutical Regulatory Agency has yet to approve Sputnik V while Health director-general Tan Sri Dr Noor Hisham Abdullah told reporters recently the vaccine is still under review.

以上